Medicated aerosol delivery.
Recent literature abounds with data which supports the need to give greater consideration to the metered dose inhaler as a therapeutically effective and more cost effective method of in-hospital aerosolized bronchodilator delivery. Patients are increasingly asked to assume a larger role in their own care following discharge, making opportunities such as in-hospital self-administered aerosol therapy too important of a tool to pass up. Hospitals are under increasing pressure to provide a greater range of health care services with existing resources. Existing procedures such as medicated aerosol therapy which can be provided as effectively but more efficiently in an alternative fashion while increasing patient involvement in their own care can simply no longer be overlooked.